Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tommaso Guerra

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 16, 2022
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS RegisterPietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, et al.
Journal of Neurology|March 10, 2026
HerMeS: a registry-based evaluation of the HERCULES criteria for identifying nonrelapsing SPMSTommaso Guerra, Giuseppe Lucisano, Maria A Rocca, et al.
JAMA Neurology|November 27, 2023
Multiple Sclerosis Progression and Relapse Activity in ChildrenPietro Iaffaldano, Emilio Portaccio, Giuseppe Lucisano, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 4, 2026
Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study)Damiano Paolicelli, Giuseppe Lucisano, Alessia Manni, et al.
Journal of Neurology|December 22, 2023
Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS RegistryPietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 16, 2022
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS RegisterPietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, et al.
Journal of Neurology|March 10, 2026
HerMeS: a registry-based evaluation of the HERCULES criteria for identifying nonrelapsing SPMSTommaso Guerra, Giuseppe Lucisano, Maria A Rocca, et al.
JAMA Neurology|November 27, 2023
Multiple Sclerosis Progression and Relapse Activity in ChildrenPietro Iaffaldano, Emilio Portaccio, Giuseppe Lucisano, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 4, 2026
Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study)Damiano Paolicelli, Giuseppe Lucisano, Alessia Manni, et al.
Journal of Neurology|December 22, 2023
Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS RegistryPietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, et al.
Pageof 3